were given anti-tumor treatments. In tumors that responded well to treatments, the number of neutrophils increased significantly.
"We discovered that neutrophils are in fact much more diverse than previously thought. Those we observe in response to immunotherapies are very different from those detected in progressing tumors and carry distinct markers. Furthermore, if we block the response of these particular neutrophils, the benefits of the treatment disappear.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: